BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17237272)

  • 1. MRP8/ABCC11 directly confers resistance to 5-fluorouracil.
    Oguri T; Bessho Y; Achiwa H; Ozasa H; Maeno K; Maeda H; Sato S; Ueda R
    Mol Cancer Ther; 2007 Jan; 6(1):122-7. PubMed ID: 17237272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCC11/MRP8 confers pemetrexed resistance in lung cancer.
    Uemura T; Oguri T; Ozasa H; Takakuwa O; Miyazaki M; Maeno K; Sato S; Ueda R
    Cancer Sci; 2010 Nov; 101(11):2404-10. PubMed ID: 20718756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites.
    Pratt S; Shepard RL; Kandasamy RA; Johnston PA; Perry W; Dantzig AH
    Mol Cancer Ther; 2005 May; 4(5):855-63. PubMed ID: 15897250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine.
    Guo Y; Kotova E; Chen ZS; Lee K; Hopper-Borge E; Belinsky MG; Kruh GD
    J Biol Chem; 2003 Aug; 278(32):29509-14. PubMed ID: 12764137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCC11/MRP8 polymorphisms affect 5-fluorouracil-induced severe toxicity and hepatic expression.
    Magdy T; Arlanov R; Winter S; Lang T; Klein K; Toyoda Y; Ishikawa T; Schwab M; Zanger UM
    Pharmacogenomics; 2013 Sep; 14(12):1433-48. PubMed ID: 24024896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU.
    Liu J; Skradis A; Kolar C; Kolath J; Anderson J; Lawson T; Talmadge J; Gmeiner WH
    Nucleosides Nucleotides; 1999 Aug; 18(8):1789-802. PubMed ID: 10478484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5-fluorouracil derivative drug S-1 treatment in non-small cell lung cancer.
    Uemura T; Oguri T; Maeno K; Sone K; Takeuchi A; Fukuda S; Kunii E; Takakuwa O; Kanemitsu Y; Ohkubo H; Takemura M; Ito Y; Niimi A
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1229-1239. PubMed ID: 31529207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive interaction between 5-FU and FdUMP[10] in the inhibition of human colorectal tumor cell proliferation.
    Liu J; Kolath J; Anderson J; Kolar C; Lawson TA; Talmadge J; Gmeiner WH
    Antisense Nucleic Acid Drug Dev; 1999 Oct; 9(5):481-6. PubMed ID: 10555156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil.
    Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA
    Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor alpha expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells.
    Honorat M; Mesnier A; Vendrell J; Guitton J; Bieche I; Lidereau R; Kruh GD; Dumontet C; Cohen P; Payen L
    Endocr Relat Cancer; 2008 Mar; 15(1):125-38. PubMed ID: 18310281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of putative binding sites for cyclic guanosine monophosphate and the anti-cancer drug 5-fluoro-2'-deoxyuridine-5'-monophosphate on ABCC11 in silico models.
    Honorat M; Terreux R; Falson P; Di Pietro A; Dumontet C; Payen L
    BMC Struct Biol; 2013 May; 13():7. PubMed ID: 23641929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calpain regulates thymidylate synthase-5-fluoro-dUMP complex levels associated with response to 5-fluorouracil in gastric cancer cells.
    Nabeya Y; Suzuki T; Furuya A; Koide N; Ohkoshi M; Takiguchi M; Ochiai T; Matsubara H; Hiwasa T
    Cancer Sci; 2011 Aug; 102(8):1509-15. PubMed ID: 21561529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer.
    Delhorme JB; Bersuder E; Terciolo C; Vlami O; Chenard MP; Martin E; Rohr S; Brigand C; Duluc I; Freund JN; Gross I
    Biomed Pharmacother; 2022 Mar; 147():112630. PubMed ID: 35051860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for 5-fluorouracil resistance in human colon cancer DLD-1 cells.
    Inaba M; Naoe Y; Mitsuhashi J
    Biol Pharm Bull; 1998 Jun; 21(6):569-73. PubMed ID: 9657039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of underlying molecular mechanism of 5-Fluorouracil chemoresistance and its restoration using fish oil in experimental colon carcinoma.
    Rani I; Kumar S; Sharma B; Prasad R; Kaur S; Sharma P; Agnihotri N
    Mol Cell Biochem; 2021 Mar; 476(3):1517-1527. PubMed ID: 33392922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
    Lu F; Hou YQ; Song Y; Yuan ZJ
    Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted drug delivery to chemoresistant cells: folic acid derivatization of FdUMP[10] enhances cytotoxicity toward 5-FU-resistant human colorectal tumor cells.
    Liu J; Kolar C; Lawson TA; Gmeiner WH
    J Org Chem; 2001 Aug; 66(17):5655-63. PubMed ID: 11511236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells.
    Kawabata S; Oka M; Shiozawa K; Tsukamoto K; Nakatomi K; Soda H; Fukuda M; Ikegami Y; Sugahara K; Yamada Y; Kamihira S; Doyle LA; Ross DD; Kohno S
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1216-23. PubMed ID: 11162657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of thymidine phosphorylase in the induction of early growth response protein-1 and thrombospondin-1 by 5-fluorouracil in human cancer carcinoma cells.
    Matsushita S; Ikeda R; Nishizawa Y; Che XF; Furukawa T; Miyadera K; Tabata S; Ushiyama M; Tajitsu Y; Yamamoto M; Takeda Y; Minami K; Mataki H; Kanzaki T; Yamada K; Kanekura T; Akiyama S
    Int J Oncol; 2010 May; 36(5):1193-200. PubMed ID: 20372793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells.
    Chung YM; Park S; Park JK; Kim Y; Kang Y; Yoo YD
    Cancer Lett; 2000 Oct; 159(1):95-101. PubMed ID: 10974411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.